Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

Tuesday, April 2: Exaggerated claims of unbelievable results with the use of consumer products are not new in the Indian advertisement industry. But, the law of the land does explicitly prohibit and punish misleading advertisements from time to time. One such case is grabbing headlines of late. <keyword id="20083249" type="General" weightage="20" keywordseo="baba-ramdev" source="keywords">Baba Ramdev</keyword> and <keyword id="20752072" type="General" weightage="20" keywordseo="acharya-balkrishna" source="keywords">Acharya Balkrishna</keyword>, co-founder and managing director of <keyword id="19980518" type="General" weightage="100" keywordseo="patanjali" source="keywords">Patanjali</keyword>, respectively, appeared before the <keyword id="19895345" type="General" weightage="20" keywordseo="supreme-court" source="keywords">Supreme Court</keyword> today for a hearing regarding a case involving misleading advertisements. So, what exactly happened? <cmsannotation type="cmsannotation" annotationid="A case of false and misleading advertisements" comment="subhead" text="A case of false and misleading advertisements">A case of false and misleading advertisements</cmsannotation> The case began in November last year when the Supreme Court, responding to a petition by the Indian Medical Association (IMA), cautioned <keyword id="6406649" type="General" weightage="20" keywordseo="patanjali-ayurved" source="Orion">Patanjali Ayurved</keyword> against airing "false" and "misleading" claims in its advertisements about medicinal products. The IMA cited several ads that allegedly portrayed allopathic medicine and doctors negatively, claiming that companies producing ayurvedic medicines made disparaging remarks to deceive the public. Despite the Supreme Court's cautionary stance and prohibition on advertising products claiming to treat specific ailments under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, Ramdev and Balkrishna reportedly conducted a press conference, once again making misleading claims about Patanjali's ability to cure various conditions permanently. Subsequently, on February 27, the Supreme Court expressed dissatisfaction with Patanjali's continuous dissemination of false advertisements regarding medicinal cures and issued notices to the company, questioning why contempt proceedings should not be initiated. It also chastised the government for not taking action and “sitting with their eyes shut”. On March 21, the Court summoned Baba Ramdev and Balkrishna to personally appear before it on April 2 to address their failure to respond to the contempt notice regarding misleading advertisements about medicinal cures. <cmsannotation type="cmsannotation" annotationid="What’s the latest update?" comment="subhead" text="What’s the latest update?">What’s the latest update?</cmsannotation> In today's hearing, the Supreme Court criticised Ramdev and Balkrishna for their "absolute defiance" in failing to submit proper affidavits of compliance and for disregarding legal directives. The Court also rebuked Patanjali's MD for describing the Drugs and Cosmetics (Magic Remedies) Act as "archaic". Noting that Patanjali's advertisements are in the "teeth of law" of the land, the Court warned Ramdev to prepare for potential consequences. Justices Hima Kohli and Ahsanuddin Amanullah, presiding over the bench, declined to acknowledge the apology extended by Patanjali last month. Subsequently, Ramdev's attorney, reportedly with folded hands, reiterated that both Ramdev and Balakrishna were extending a personal and unconditional apology before the court. Finally, the Court has granted Ramdev and Balkrishna a final opportunity to file affidavits in one week and mandated their presence at the next hearing on April 10.

Government ‘sitting with its eyes shut’, says Supreme Court as Patanjali’s misleading advertisement case drags on

Expanding the scope of its hearing in the <keyword id="19980518" type="General" weightage="20" keywordseo="Patanjali" source="keywords">Patanjali</keyword> Ayurved case, the <keyword id="19895345" type="General" weightage="20" keywordseo="Supreme-Court" source="keywords" meta.keywordsubtype="org" meta.entityname="Supreme Court" meta.hostid="266" meta.entityid="Supreme Court">Supreme Court</keyword> on Tuesday took a stern view of <keyword id="20610549" type="General" weightage="20" keywordseo="misleading-advertisements" source="keywords">misleading advertisements</keyword> by FMCG firms and asked three Union ministries to inform it about the steps they have taken to curb the practice which takes "public for a ride" and adversely affects their health. The court passed the order after Yoga guru Ramdev and his aide Balkrishna of Patanjali Ayurved Ltd. told a bench of Justices Hima Kohli and Ahsanuddin Amanullah that they have issued unqualified public apology in as many as 67 newspapers over misleading advertisements and are willing to issue additional advertisements expressing their contrition. The bench said the public apology published in newspapers were not on record and asked those to be filed within two days. It posted the matter for April 30 for further consideration. While hearing the Patanjali case, the apex court said the implementation of the relevant provisions of the Drugs and Magic Remedies (Objectionable Advertisements) Act, the Drugs and Cosmetics Act and the Consumer Protection Act and the related rules also needed a closer examination. It said the issue was not limited to Patanjali but extended to all Fast-Moving Consumer Goods (FMCG) firms which have been issuing "misleading advertisements and taking the public for a ride, in particular affecting the health of babies, school-going children and senior citizens who have been consuming products on the basis of the said misrepresentation". "We must clarify that we are not here to gun for a particular party or a particular agency or a particular authority. This is a PIL, and in the larger interest of the consumers, public should know which way they are going and how and why they can be misled, and how authorities are acting to prevent it," the bench said. The court asked the Union ministries of consumer affairs, information and broadcasting, and information technology to explain what action they have taken to prevent the misuse of consumer laws. It also sought an explanation from the Centre over an August 2023 letter issued by the Ministry of Ayush to the licencing authorities of all states and Union Territories and drug controllers of Ayush asking them to not initiate any action under rule 170 of Drugs and Cosmetics Rules, 1945. The bench also asked the <keyword id="20083252" type="General" weightage="20" keywordseo="Indian-Medical-Association" source="keywords" meta.keywordsubtype="org" meta.entityname="Indian Medical Association" meta.hostid="266" meta.entityid="Indian Medical Association">Indian Medical Association</keyword> (IMA), the petitioner in the Patanjali advertisements case, to "put its house in order". It said several complaints have been made about alleged unethical acts by members of the IMA who prescribe highly expensive medicines and line of treatment. The bench also ordered impleading the National Medical Commission (NMC) as a respondent in the matter for effective assistance to the court. At the outset, senior advocate Mukul Rohatgi, appearing for Ramdev and Patanjali Ayurved Ltd managing director Balkrishna, told the bench they have issued on Monday unqualified apology for the "lapses" on their part. "Where? Why it is not filed?" the bench asked. Rohatgi said it was issued on Monday in 67 newspapers across the country. When the court asked the senior advocate why did the respondents wait for a whole week before publishing the public apology, Rohatgi said, "Its language had to be changed". The court also quizzed him about the size of advertisements. "Is it the same size of advertisements that you normally issue in newspapers?" it asked Rohatgi, who submitted "It costs tens of lakhs (of rupees)". The bench ordered that the apology published be filed on record and added it wanted to see the actual advertisement published in newspapers. "The said advertisements are not on record. It is submitted that the same have been collated and shall be filed in the course of the day with copies to counsel for the parties. Needful shall be done within two days with copies to counsel for the parties," it said. The counsel said additional advertisement shall be issued by Ramdev and Balkrishna tendering unqualified apology for the lapses on their part. The bench said it was necessary to implead the three central ministries in order to examine the steps taken to prevent the abuse of the Drugs and Magic Remedies (Objectionable Advertisements) Act and rules, the Drugs and Cosmetics Act and the Consumer Protection Act. It said these ministries shall file affidavits enunciating the action they have taken to prevent the misuse/abuse of these statutes along with the relevant data since 2018. The bench said licencing authorities of all states and UTs shall also be impleaded as co-respondents in the matter. The bench told the IMA's counsel that while they are pointing fingers at Patanjali, "the other four fingers are also pointing at you (IMA)". On April 16, the apex court had warned Ramdev and Balkrishna against any attempt to "degrade allopathy" and permitted them to tender a "public apology and show contrition" within a week in the contempt proceedings in the misleading advertisements case against Patanjali Ayurved Ltd. The apex court is hearing a plea filed in 2022 by the IMA alleging a smear campaign against the Covid vaccination drive and modern systems of medicine. Ramdev and Balkrishna had earlier tendered an "unconditional and unqualified apology" before the top court over advertisements issued by the firm making tall claims about the medicinal efficacy of its products. SEE ALSO:<a href="https://www.businessinsider.in/tech/mobile/news/google-pixel-8a-may-be-more-expensive-than-its-predecessor-as-per-a-new-leak/articleshow/109499394.cms" target="_blank"></a> <a href="https://www.businessinsider.in/tech/mobile/news/google-pixel-8a-may-be-more-expensive-than-its-predecessor-as-per-a-new-leak/articleshow/109499394.cms" target="_blank">Google Pixel 8a may be more expensive than its predecessor, as per a new leak</a><a href="https://www.businessinsider.in/tech/mobile/webstories/best-smartphones-under-25000-in-india/slidelist/109529634.cms" target="_blank"></a> <a href="https://www.businessinsider.in/tech/mobile/webstories/best-smartphones-under-25000-in-india/slidelist/109529634.cms" target="_blank">Best smartphones under ₹25,000 in India</a><a href="https://www.businessinsider.in/sports/webstories/at-17-indian-chess-prodigy-d-gukesh-becomes-youngest-challenger-for-world-championship/slidelist/109492021.cms" target="_blank"></a> <a href="https://www.businessinsider.in/sports/webstories/at-17-indian-chess-prodigy-d-gukesh-becomes-youngest-challenger-for-world-championship/slidelist/109492021.cms" target="_blank">At 17, Indian chess prodigy D Gukesh becomes youngest challenger for World Championship</a>

Supreme Court expands Patanjali misleading ads hearing to include FMCG companies

The <keyword id="19895345" type="General" weightage="20" keywordseo="Supreme-Court" source="keywords">Supreme Court</keyword>, on Tuesday, granted one-week time to yoga guru <keyword id="20055079" type="General" weightage="100" keywordseo="Ramdev" source="keywords">Ramdev</keyword>, his aide <keyword id="21172332" type="General" weightage="20" keywordseo="Balkrishna" source="keywords">Balkrishna</keyword> and <keyword id="20083247" type="General" weightage="20" keywordseo="Patanjali-Ayurved" source="keywords" meta.keywordsubtype="org" meta.entityname="Patanjali Ayurved" meta.hostid="261" meta.entityid="Patanjali Ayurved">Patanjali Ayurved</keyword> to issue a <keyword id="114576" type="General" weightage="20" keywordseo="public-apology" source="Orion">public apology</keyword> in the misleading advertisements case, but said it was not letting them "<keyword id="2308348" type="General" weightage="20" keywordseo="off-the-hook" source="Orion">off the hook</keyword>" now. Both Ramdev and Balkrishna were present during the hearing and personally tendered an unqualified apology to the apex court. A bench of Justices Hima Kohli and Ahsanuddin Amanullah took note of their apologies, but made it clear that at this stage it has not decided to "let them off the hook". "You are doing good work but you can't degrade allopathy," the bench told Balkrishna while interacting with him. Ramdev, who also interacted with the bench, said he had no intention to show disrespect to the court in any manner. However, the bench told Balkrishna that they (<keyword id="6356684" type="General" weightage="20" keywordseo="patanjali" source="Orion">Patanjali</keyword>) are not so innocent that they didn't know what the top court had said in its earlier orders in the case. "I am willing to give a public apology," senior advocate Mukul Rohatgi, appearing for Ramdev and Balkrishna, told the bench at the outset. The apex court asked Ramdev and Balkrishna, both of whom were present in the court, to come forward for an interaction with the bench. "They should feel they have a connect with the court," the bench said. The apex court has now posted the matter for further hearing on April 23. Ramdev and Balkrishna had last week tendered an "unconditional and unqualified apology" before the top court over advertisements issued by the firm making tall claims about the medicinal efficacy of its products. In two separate affidavits filed in the court, Ramdev and Balkrishna have tendered an unqualified apology for the "breach of the statement" recorded in the November 21 last year order of the apex court. In the November 21, 2023 order, the top court had noted that counsel representing Patanjali Ayurved had assured it that "henceforth there shall not be any violation of any law(s), especially relating to advertising or branding of products manufactured and marketed by it and, further, that no casual statements claiming medicinal efficacy or against any system of medicine will be released to the media in any form". The top court had said Patanjali Ayurved Ltd is "bound down to such assurance". The non-observance of the specific assurance and the subsequent media statements irked the apex court, which later issued a notice to them to explain why contempt proceedings be not initiated against them.

Patanjali ads case: Supreme Court asks Ramdev, Balkrishna to issue public apology; says not letting them off hook yet

<ul><li>Within the category, <keyword id="6373748" type="DOMAIN" weightage="20" keywordseo="dabur-india">Dabur India</keyword> was the top advertiser on TV, Radio &amp; Digital mediums.</li><li>More than 80% of the category ad volumes was on the news channel genre during Mar-May ’20 on TV. </li><li>More than 70% share of category ad volumes were during Prime Time, Afternoon&amp; Morning time bands on TV. </li></ul>Advertising of the <keyword id="539809" type="PERSON" weightage="20" keywordseo="chyawanprash">Chyawanprash</keyword> category increased on TV, Radio &amp; Digital medium during Mar-May ’20, according to the latest TAM AdEx overview. Dabur India was the top advertiser on TV, Radio &amp; Digital mediums. The data also revealed that more than 80% of the category ad volumes was on the news channel genre during Mar-May ’20 on TV. More than 70% share of category ad volumes were during Prime Time, Afternoon&amp; Morning time bands on TV. Advertising of the category on TV grew by 8 times in Mar-May’20. Meanwhile, category advertising on Digital surged by 2639 times in Mar-May’20 . Less than 20 seconds and 20-40 seconds ads covered 75% and 25% share respectively on TV during Mar-May ’20. Ad Network and Programmatic transaction method together captured more than 3/4th of Chyawanprash ad insertions on Digital. The report also stated that in May’20, count of advertisers and brands increased compared to Apr’20 across TV, Print&amp; Digital mediums in the Chyawanprash category. This increase comes in the wake of the spread of <keyword id="1754604" type="PERSON" weightage="20" keywordseo="coronavirus">Coronavirus</keyword> when people have become more health conscious and are looking for ways of strengthening and boosting their immunity.

Advertising of Chyawanprash on TV grew by 8 times between March and May this year: TAM AdEx Overview

(Eds: Updates with Ayush Ministry statement) Haridwar/New Delhi, Jun 23 () Yoga guru Ramdev's herbal medicine company Patanjali Ayurved on Tuesday claimed to have discovered a medicine that could cure coronavirus in just seven days - a claim that the Ayush Ministry scoffed at by seeking stopping of advertisements for the drug. While Ramdev claimed that Ayurved-based 'Coronil and Swasari' medicine have shown 100 per cent favourable results during clinical trials on COVID-19 infected patients except those on a life support system, the Ayush Ministry sought from the company detailed report on composition, testing and other data of the drugs. The ministry also used powers under a 1954 law to ask the firm to "stop advertising/publicizing" claims of corona cure drug until the issue is examined by it. A government notification bars companies from advertising a cure without government approval. But it wasn't immediately clear if the drug can still be sold. Talking to , Ramdev said the medicines have been developed by Patanjali Research Center, Haridwar and privately-owned National Institute of Medical Science, Jaipur following all protocols with clinically controlled trial-based evidence. "Patanjali first conducted clinical case study and conducted clinical control trials following all protocols of drug discovery," he said. Sidestepping questions on the drug being approved by government agencies such as ICMR, Ramdev said clinical controlled study of these medicines was done in several cities including Delhi, Ahmedabad and Meerut and the RCT (Randomized Clinical Trial) controlled with placebo was conducted at Jaipur-based National Institute of Medical Sciences &amp; Research. "This was done after getting approval from Clinical Trial Registry of India (CTRI) and all other required formalities," he said. "We have followed all the parameters set up by modern science for such clinical trials." Reacting to the announcement, the Ministry of Ayush issued a statement saying, "Facts of the claim and details of the stated scientific study are not known" to it. "Patanjali Ayurved Ltd has been asked to provide at the earliest details of the name and composition of the medicines being claimed for COVID treatment; site(s)/hospital(s), where the research study was conducted for COVID-19; protocol, sample size, Institutional Ethics Committee clearance, CTRI registration and results data of the study (ies) and stop advertising/publicizing such claims till the issue is duly examined," the ministry statement said. The ministry also asked the concerned State Licensing Authority of Uttarakhand Government to provide copies of license and product approval details of the Ayurvedic medicines being claimed for the treatment of COVID -19. Under the ministry's guidelines for drug development of ayurvedic formulations, state licensing authority grants licenses for manufacturing any Ayurvedic, Siddha or Unani medicine. Ramdev at a launch press conference in Haridwar, where his company is based, claimed that his ayurvedic drugs have shown 100 per cent favourable results during the clinical trial. "We conducted a clinical case study and clinical controlled trial, and found 69 per cent patients recovered in 3 days and 100 patients recovered in 7 days," he said. According to him, this medicine is useful for prevention from COVID-19 and also for treatment. Claiming that during the trial other complications of patients were also cured and their critical parameters were normalised, he said no infected patient lost his life during the trial. Patanjali, he said, had started to work on corona medicines in December 2019. The Corona kit, priced at Rs 545, would be available pan India within a week. The kit will have medicines for 30 days. Ramdev said the medicines can be ordered online through a mobile app from next Monday. The COVID-19 therapy suggested by Patanjali is applicable for adults ranging between 15-80 years of age whereas children are advised to take half the dosage prescribed for adults. Patanjali's anti-COVID tablet, Divya Coronil Tablet consists of Giloy, Tulsi and Ashwagandha and is prescribed to be taken thrice a day with hot water 30 minutes after breakfast, lunch and dinner. Medical experts, however, were not convinced by the claims. Dr Ravi Shekhar Jha, Head of the department and senior consultant, Pulmonology, Fortis Escorts Hospital, Faridabad, said physiologically it is quite impossible that there is any medicine which can finish the viral load from the body in 5-7 days. "These claims can be very harmful because people, instead of taking actual medical help, may start rushing to these kinds of claims which have no proven clinical trial," he told . Instead of taking actual medical help, opting for a "desi nuskha" kind of a thing is just going to result in loss of precious time in curing the disease, Jha said. Noted city-based lung surgeon Dr Arvind Kumar said only a proper clinical trial can prove the efficacy of the medicine. Haridwar-based Patanjali group has an estimated turnover of around Rs 10,500 crore. It had acquired debt-ridden Ruchi Soya in a corporate insolvency resolution process for around Rs 4,350 crore after competing with Adani Group. The group is also known for venturing in uncharted areas as it had in August 2018 launched a messaging app 'Kimbho', which could not take off and is now defunct. ALM KRH ANZ MR

Ramdev's Patanjali claims to have COVID-19 medicine; Ayush Ministry frowns

Advertising sector watchdog <keyword id="169284" type="ORGANIZATION" weightage="20" keywordseo="ASCI">ASCI</keyword> has rapped <keyword id="6356684" type="UNKNOWN" weightage="20" keywordseo="patanjali">Patanjali</keyword> Ayurved for "false and misleading" claims in its various advertisements , including for its hair oil and washing powder brands. 
 
The watchdog has ruled that the advertisements of the group associated with Yoga Guru Ramdev "unfairly denigrates" other products in the market. 
 The Customer Complaints Council (CCC) of <keyword id="382559" type="ORGANIZATION" weightage="20" keywordseo="Advertising-Standard-Council-of-India">Advertising Standard Council of India</keyword> (ASCI) has also upheld complaints against advertisements by Johnson &amp; Johnson, Amazon and ITC, among other companies. 
 
In March, the CCC received 156 complaints, out of which it upheld as many as 90 complaints, terming them as "false and misleading". The upheld complaints included 32 in the education category, 30 in the healthcare and personal care category, and further 10 in the food and beverages category. 
 The CCC found Patanjali's advertisement claim for its product <keyword id="3380075" type="UNKNOWN" weightage="20" keywordseo="Patanjali-Kesh-Kanti-Natural-Hair-Cleanser-and-Oil">Patanjali Kesh Kanti Natural Hair Cleanser and Oil</keyword> that "mineral oil is carcinogenic in nature and may cause cancer" was false and misleading by ambiguity and by gross exaggeration. 
 
It also upheld complaints against Patanjali Ayurved's Patanjali Kachi Ghani Mustard Oil . 
 
"The advertisement's claims 'Other than Kacchi Ghani process most of the other edible refined oils and mustard oil are made using neurotoxin Hexagon solvent extraction process. To make profits at the cost of consumers' health many companies mix cheap palm oil in mustard oil", were not substantiated and the claims were misleading," it said. 
 
"The statement also unfairly denigrates other oils/ mustard oil," the advertising watchdog added. 
 
The advertising watchdog also upheld complaint against Patanjali Ayurved's Patanjali Herbal Washing Powder, Cake and Dishwash Bar. 
 
Johnson &amp; Johnson Ltd advertisement's claim on Benadryl DR was pulled up. CCC ruled that the claim "sookhi khansi ko dobara aane se roke (meaning - stops dry cough from reoccurring') is an absolute claim and was not substantiated...The claim is misleading by exaggeration". 
 
FMCG firm ITC was pulled for its advertisement on Aashirvaad Multigrain Atta. 
 
"The advertisement's claim 'India's No 1 Atta' is misleading by ambiguity as the claim support was for the mother brand Aashirvaad whereas the advertised product was only one variant i.e. Aashirvaad Atta with Multigrains. Also, the disclaimer was not as per Nielsen criteria," it said. 
 
Complaint against Kalyan Jewellers was upheld for making 'substantiated claim and misleading by exaggeration" that "Kalyan Jewellers is the biggest jewellery showroom in the world."

Patanjali rapped for 'false and misleading' hair oil, washing powder ads

It’s not even been a month that yoga guru <keyword id="6355107" type="PERSON" weightage="100" keywordseo="Baba-Ramdev">Baba Ramdev</keyword>’s FMCG company called <keyword id="6356684" type="UNKNOWN" weightage="100" keywordseo="patanjali">Patanjali</keyword> faced flak because of its <keyword id="442416" type="UNKNOWN" weightage="100" keywordseo="misleading-ads">misleading ads</keyword> for its hair oil and washing powder brands, and the company has again found itself under the radar of India’s ad authorities. 
 <keyword id="169284" type="ORGANIZATION" weightage="100" keywordseo="ASCI">ASCI</keyword> has objected to several ads run by the company, including the one for its best-selling product, the '<keyword id="3319699" type="UNKNOWN" weightage="100" keywordseo="Dant-Kanti">Dant Kanti</keyword>' toothpaste. Reportedly, ASCI has found the ad misleading, along with the ones for its mustard oil (Kachi Ghani), fruit juices and cattle feed (Dhugdhamrit) products. 
 ASCI and India’s apex food regulator Food Safety and Standards Regulator of India (<keyword id="154680" type="ORGANIZATION" weightage="100" keywordseo="FSSAI">FSSAI</keyword>) have signed an MoU, under which ASCI would be checking misleading ads in the food and beverage sector. 
 
As per ASCI, Dant Kanti's ads claim that the product is "Effective Against Pyorrhoea, Swelling &amp; Bleeding of Gums, Yellowing of Teeth, Sensitivity &amp; Bad Breath" and "protects your teeth for a longer time and provides a natural shield against germs." However, these claims are not substantiated and thus can mislead the customers. 
 
ASCI has also raised objections against several other companies, like HUL, P&amp;G, Kellogg India, L'Oreal India and Colgate-Palmolive, for misleading claims made in advertisements for a variety of products.

The Ads authority in India is very angry about Patanjali’s misleading advertisements

Guess who India's biggest <keyword id="3234554" type="UNKNOWN" weightage="80" keywordseo="FMCG-advertiser">FMCG advertiser</keyword>, at least for now is? It’s none other than the Baba Ramdev-led <keyword id="672744" type="ORGANIZATION" weightage="80" keywordseo="Patanjali-Ayurved-Ltd">Patanjali Ayurved Ltd</keyword>. For the seven days to January 29, TV commercials (TVCs) of products under the Patanjali brand outnumbered those from big consumer goods brands such as <keyword id="6399124" type="CITY" weightage="80" keywordseo="Cadbury">Cadbury</keyword>, <keyword id="29464" type="PERSON" weightage="80" keywordseo="Parle">Parle</keyword> and Pond's. 
 
The data is from Broadcast Audience Research Council (BARC), the joint industry body that compiles and publishes TV viewing data. BARC monitors around 450 channels. TVCs for Patanjali products played more than 17,000 times between January 23 and January 29 compared with just under 16,000 times for products under the Cadbury brand. 
 
These seemingly high numbers are explained by the fact that TV commercials play in a very large number of channels in many genres across India, both nationally and regionally. 
 Patanjali grabbing the number one spot this week may turn out to be significant over the medium term, especially since the climb has been steep. A week prior to this latest release, BARC's TVC count showed Patanjali in the sixth rank. <keyword id="6355107" type="PERSON" weightage="80" keywordseo="Baba-Ramdev">Baba Ramdev</keyword>'s brand came into the top ten only from November last year. 
 
Ramdev had said in 2015 that his company will be India's biggest fast moving consumer goods (FMCG) player in five years. For its TV advertising blitz, Patanjali has picked seven products from a 30-strong product portfolio. 
 
These seven are clarified butter (ghee), shampoo, biscuits, noodles, honey, dental cream and aloe vera cream. Baba Ramdev's spokesperson SK Tijarawala said it has been a conscious decision on the part of the company to show its ads largely in news channels to target the "intelligent audience." 
 
"We got the first ranking this week also because of all our seven TV commercials were rolled in together this time. We are coming out seven more products, so there are more ads in the pipeline." 
 
There have been reports, not denied by Patanjali, that the company has earmarked Rs 300 crore for ad spend. Tijarawala did not comment on this but said the flood of ads was to make Patanjali a "recallable brand" and that opting for news channels meant lower rates and, therefore, greater frequency of ads. Some advertising professionals were, however, skeptical of the audience pulling power of Patanjali ads. 
 
Image credit: Indiatimes

You Searched For "Patanjali advertisements" and got 8 results

Government ‘sitting with its eyes shut’, says Supreme Court as Patanjali’s misleading advertisement case drags on

Kunal Kambli

Supreme Court expands Patanjali misleading ads hearing to include FMCG companies

PTI

Patanjali ads case: Supreme Court asks Ramdev, Balkrishna to issue public apology; says not letting them off hook yet

PTI

Advertising of Chyawanprash on TV grew by 8 times between March and May this year: TAM AdEx Overview

BI India Partner

Ramdev's Patanjali claims to have COVID-19 medicine; Ayush Ministry frowns

PTI

Patanjali rapped for 'false and misleading' hair oil, washing powder ads

BI India Bureau

The Ads authority in India is very angry about Patanjali’s misleading advertisements

BI India Bureau

Baba Ramdev's Patanjali Ayurved Ltd becomes India's biggest FMCG advertiser this week leaving behind Parle, Cadbury

BI India Bureau

Popular Keywords

Buying Guides